Does Rectal Indomethacin Eliminate the Need for Prophylactic Pancreatic Stent Placement in Patients Undergoing High-Risk ERCP? Post hoc Efficacy and Cost-Benefit Analyses Using Prospective Clinical Trial Data

OBJECTIVES: A recent large-scale randomized controlled trial (RCT) demonstrated that rectal indomethacin administration is effective in addition to pancreatic stent placement (PSP) for preventing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) in high-risk cases. We per...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Elmunzer, B. Joseph, Higgins, Peter D.R., Saini, Sameer D., Scheiman, James M., Parker, Robert A., Chak, Amitabh, Romagnuolo, Joseph, Mosler, Patrick, Hayward, Rodney A., Elta, Grace H., Korsnes, Sheryl J., Schmidt, Suzette E., Sherman, Stuart, Lehman, Glen A., Fogel, Evan L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3947644/
https://ncbi.nlm.nih.gov/pubmed/23295278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ajg.2012.442
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi